Feeling the stress of announcing their availability on LinkedIn, a group of creatives banded together to document their experience in a comedic film — and sparked a movement in the process.
GSK offers $1.5B for CureVac’s mRNA vaccines, CureVac axes 30% of staff
The internal restructuring comes months after John Crowley, an alum of Bristol Myers Squibb, Novazyme and Amicus Therapeutics, took over as CEO of BIO.
Weber Shandwick lays off about 20 people in New York and Chicago
Following a recent proxy battle with activist investor Sarissa Capital and facing decreased revenue, the company will restructure in an attempt to maintain cash flow.
AI Deciphered: Discovering the Potential for Marketers and Communicators